feed,title,long_url,short_url
Benzinga,Celltrion Develops Tailored Neutralising Antibody Cocktail Treatment with CT-P59 to Tackle COVID-19 Variant Spread Using Its Antibody Development Platform,https://www.benzinga.com/pressreleases/21/02/b19606013/celltrion-develops-tailored-neutralising-antibody-cocktail-treatment-with-ct-p59-to-tackle-covid-1,https://j.mp/3rHid6F
Benzinga,Alcanna Inc. and YSS Corp. Announce Closing of Subscription Receipt Private Placement,https://www.benzinga.com/pressreleases/21/02/n19605994/alcanna-inc-and-yss-corp-announce-closing-of-subscription-receipt-private-placement,https://j.mp/2LHVgRC
Benzinga,Full-year 2020 results & strategic update,https://www.benzinga.com/pressreleases/21/02/g19605990/full-year-2020-results-strategic-update,https://j.mp/3tOTUWv
